Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.
With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.
05:40 - The panel introduce Oncodermatology and how many patients experience dermatological toxicities
09:07 - Dr Beth McLellan explains how patients can choose chemotherapies based on the side-effects
11:29 - Dr Nicole LeBoeuf discusses how hair retention is more than vanity, but can give patients a sense of privacy and normalcy
13:50 - What role can an Oncodermatologist play in preventing these side-effects?
14:47 - Why Oncodermatology needs to be preventative, rather than curative
16:28 - Teledermatology
19:00 - Oncodermatology as an emerging field
26:37 - Grading adverse events in Dermatology
31:01 - The Oncodermatology role in scalp cooling
31:59 - Where do the panel see Oncodermatology in 10 years time?
Dr Corina van den Hurk, Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall
Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.
With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.
Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.
With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.
05:40 - The panel introduce Oncodermatology and how many patients experience dermatological toxicities
09:07 - Dr Beth McLellan explains how patients can choose chemotherapies based on the side-effects
11:29 - Dr Nicole LeBoeuf discusses how hair retention is more than vanity, but can give patients a sense of privacy and normalcy
13:50 - What role can an Oncodermatologist play in preventing these side-effects?
14:47 - Why Oncodermatology needs to be preventative, rather than curative
16:28 - Teledermatology
19:00 - Oncodermatology as an emerging field
26:37 - Grading adverse events in Dermatology
31:01 - The Oncodermatology role in scalp cooling
31:59 - Where do the panel see Oncodermatology in 10 years time?
Dr Corina van den Hurk, Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall
